BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 30517915)

  • 21. Low-grade squamous intraepithelial lesion/cannot exclude high-grade squamous intraepithelial lesion (LSIL-H) is a unique category of cytologic abnormality associated with distinctive HPV and histopathologic CIN 2+ detection rates.
    Barron S; Li Z; Austin RM; Zhao C
    Am J Clin Pathol; 2014 Feb; 141(2):239-46. PubMed ID: 24436272
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Usefulness of p16
    Miralpeix E; Genovés J; Maria Solé-Sedeño J; Mancebo G; Lloveras B; Bellosillo B; Alameda F; Carreras R
    Mod Pathol; 2017 Feb; 30(2):304-310. PubMed ID: 27739439
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Predictor factors for conservative management of cervical intraepithelial neoplasia grade 2: Cytology and HPV genotyping.
    Salvadó A; Miralpeix E; Solé-Sedeno JM; Kanjou N; Lloveras B; Duran X; Mancebo G
    Gynecol Oncol; 2021 Sep; 162(3):569-574. PubMed ID: 34226019
    [TBL] [Abstract][Full Text] [Related]  

  • 24. HPV genotyping for triage of women with abnormal cervical cancer screening results: a multicenter prospective study.
    Nakamura Y; Matsumoto K; Satoh T; Nishide K; Nozue A; Shimabukuro K; Endo S; Nagai K; Oki A; Ochi H; Morishita Y; Noguchi M; Yoshikawa H
    Int J Clin Oncol; 2015 Oct; 20(5):974-81. PubMed ID: 25652908
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical importance of "low-grade squamous intraepithelial lesion, cannot exclude high-grade squamous intraepithelial lesion (LSIL-H)" terminology for cervical smears 5-year analysis of the positive predictive value of LSIL-H compared with ASC-H, LSIL, and HSIL in the detection of high-grade cervical lesions with a review of the literature.
    Ince U; Aydin O; Peker O
    Gynecol Oncol; 2011 Apr; 121(1):152-6. PubMed ID: 21211831
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The Positive Predictive Value of High-Grade Squamous Intraepithelial Lesion on Cytology for the Histological Diagnosis of Cervical Intraepithelial Neoplasia 2 or Higher: A Systematic Review.
    Karia N; Van Loon A; Simoens C; Benoy I; Bogers J
    Acta Cytol; 2019; 63(3):206-214. PubMed ID: 30947186
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Whole-Slide Imaging of Pap Cellblock Preparations Is a Potentially Valid Screening Method.
    Tawfik O; Davis M; Dillon S; Tawfik L; Diaz FJ; Amin K; Fan F
    Acta Cytol; 2015; 59(2):187-200. PubMed ID: 25967603
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Are Women with Antecedent Low-Grade Cytology and <CIN2 Findings in Colposcopy Being Overmanaged?
    Piedmonte S; Tsang K; Jembere N; Murphy J; McCurdy B; Sacco J; Kupets R
    J Obstet Gynaecol Can; 2022 Oct; 44(10):1054-1060. PubMed ID: 35948169
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Follow up in women with biopsy diagnosis of cervical low-grade squamous intraepithelial lesion (LSIL): how long should it be?
    Ciavattini A; Clemente N; Tsiroglou D; Sopracordevole F; Serri M; Delli Carpini G; Papiccio M; Cattani P
    Arch Gynecol Obstet; 2017 Apr; 295(4):997-1003. PubMed ID: 28255767
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Histological outcomes in conventional cervical cytology for invasive carcinoma: not always cancer.
    Peixoto Pereira FR; Soares LC; de Oliveira MAP
    J Obstet Gynaecol; 2017 Nov; 37(8):1112-1114. PubMed ID: 28657397
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Histology correlation with atypical squamous cells of undetermined significance (ASCUS) and low-grade squamous intraepithelial lesion (LSIL) cytology diagnoses: An argument to ensure ASCUS follow-up that is as aggressive as that for LSIL.
    Dvorak KA; Finnemore M; Maksem JA
    Diagn Cytopathol; 1999 Oct; 21(4):292-5. PubMed ID: 10495326
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Absence or Presence of High-Grade Squamous Intraepithelial Lesion in Cervical Conization Specimens: A Clinicopathologic Study of 540 Cases.
    Walavalkar V; Stockl T; Owens CL; Manning M; Papa D; Li A; Khan A; Liu Y
    Am J Clin Pathol; 2016 Jan; 145(1):96-100. PubMed ID: 26712876
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Human papillomavirus testing versus repeat cytology for triage of minor cytological cervical lesions.
    Arbyn M; Roelens J; Simoens C; Buntinx F; Paraskevaidis E; Martin-Hirsch PP; Prendiville WJ
    Cochrane Database Syst Rev; 2013 Mar; 2013(3):CD008054. PubMed ID: 23543559
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Risk of invasive cervical cancer after atypical glandular cells in cervical screening: nationwide cohort study.
    Wang J; Andrae B; Sundström K; Ström P; Ploner A; Elfström KM; Arnheim-Dahlström L; Dillner J; Sparén P
    BMJ; 2016 Feb; 352():i276. PubMed ID: 26869597
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Significance of subclassifying high-grade squamous intraepithelial lesions into moderate dysplasia/CIN II versus severe dysplasia/CIN III/CIS in the Bethesda System terminology.
    Howell LP; Zhou H; Wu W; Davis R
    Diagn Cytopathol; 2004 May; 30(5):362-6. PubMed ID: 15108239
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Should LSIL-H be a distinct cytology category?: A study on the frequency and distribution of 40 human papillomavirus genotypes in 808 women.
    Zhou H; Schwartz MR; Coffey D; Smith D; Mody DR; Ge Y
    Cancer Cytopathol; 2012 Dec; 120(6):373-9. PubMed ID: 22648956
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cytological Analysis of Low-grade Squamous Intraepithelial Lesion with a Histodiagnosis of Cervical Intraepithelial Neoplasia 3 (Severe Dysplasia) Prospectively.
    Washiya K; Saito C; Nanjo H; Sugiyama T; Abe K; Watanabe J
    Anal Quant Cytopathol Histpathol; 2015 Jun; 37(3):153-8. PubMed ID: 26173352
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Histopathologic extent of cervical intraepithelial neoplasia 3 lesions in the atypical squamous cells of undetermined significance low-grade squamous intraepithelial lesion triage study: implications for subject safety and lead-time bias.
    Sherman ME; Wang SS; Tarone R; Rich L; Schiffman M
    Cancer Epidemiol Biomarkers Prev; 2003 Apr; 12(4):372-9. PubMed ID: 12692113
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Distribution of human papillomavirus types in ThinPrep Papanicolaou tests classified according to the Bethesda 2001 terminology and correlations with patient age and biopsy outcomes.
    Evans MF; Adamson CS; Papillo JL; St John TL; Leiman G; Cooper K
    Cancer; 2006 Mar; 106(5):1054-64. PubMed ID: 16421920
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Minor Cytological Abnormalities and up to 7-Year Risk for Subsequent High-Grade Lesions by HPV Type.
    Persson M; Elfström KM; Olsson SE; Dillner J; Andersson S
    PLoS One; 2015; 10(6):e0127444. PubMed ID: 26083247
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.